Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Th17 cells are a distinct lineage of effector CD4+ T cells characterized by their production of interleukin (IL)-17. We demonstrate that Th17 cells also expressed IL-22, an IL-10 family member, at substantially higher amounts than T helper (Th)1 or Th2 cells. Similar to IL-17A, IL-22 expression was initiated by transforming growth factor β signaling in the context of IL-6 and other proinflammatory cytokines. The subsequent expansion of IL-22–producing cells was dependent on IL-23. We further demonstrate that IL-22 was coexpressed in vitro and in vivo with both IL-17A and IL-17F. To study a functional relationship among these cytokines, we examined the expression of antimicrobial peptides by primary keratinocytes treated with combinations of IL-22, IL-17A, and IL-17F. IL-22 in conjunction with IL-17A or IL-17F synergistically induced the expression of β-defensin 2 and S100A9 and additively enhanced the expression of S100A7 and S100A8. Collectively, we have identified IL-22 as a new cytokine expressed by Th17 cells that synergizes with IL-17A or IL-17F to regulate genes associated with skin innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are induced by IL-17 during infection (see section below) [28,31].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“S100A7 and S100A8 are strongly regulated by IL-17 and IL-22 in keratinocytes.25,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“IL-17A and IL-22 are two members of the cytokine family with substantial roles in host defense and other immunoregulatory functions.25,36,39,69–72”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
In the citing paper
“IL-22, another product of Th17 cells, appears to be protective in the bleomycin model (150)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [150]
In the citing paper
“IL-1, TNFα, IFNγ, IL-17, and IL-22 are strong inducers of hBD2 and hBD3 expression.25,36,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“Also, IL-23p19–defi cient mice are very susceptible to Citrobacter rodentium infection despite maintaining wild-type expression of IL-17A (7).”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 2×
“Similar to IL-17A and IL-17F, IL-22 induces IL-6, CXCL8, and MCP-1 expression by fi broblast cells (1, 13, 14).”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669 · cited 1×
“For example, IL-23p19–defi cient mice are completely resistant to disease in collagen-induced arthritis, whereas IL-17A– defi cient mice remain susceptible, albeit with a signifi cantly reduced incidence and severity (9, 10).”
BackgroundIL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359 · cited 7×
“Keratinocytes treated with a combination of IL-17A and IL-17F enhanced S100A8, but did not further enhance expression of hBD-2, S100A7, or S100A9.”
BackgroundInfluential
Cited by
Items 501–600 of 1,006
The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
Psoriasis and Antimicrobial Peptides
Takahashi, T., & Yamasaki, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186791 · Cited by 119
“The Th17 cytokines IL‐17A and IL‐22 are inducers of hBD2 [90].”
BackgroundComparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
Belasco, J., Louie, J. S., Gulati, N., Wei, N., Nograles, K. E., Fuentes‐Duculan, J., Mitsui, H., Suárez‐Fariñas, M., & Krueger, J. G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38995 · Cited by 137
Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica
Nakada‐Tsukui, K., & Nozaki, T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00175 · Cited by 141
Human autoantibodies underlying infectious diseases
Puel, A., Bastard, P., Bustamante, J. C., & Casanova, J. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211387 · Cited by 130
“In 2010, two independent studies reported that almost all APS-1 patients, of all ages, tested, had high serum titers of IgG auto-Abs against at least one of the Th17 cytokines (IL-17A, IL-17F, and/or IL-22; Liang et al., 2006; Zheng et al., 2007), neutralizing up to 50 ng/ml IL-17A, 10 ng/ml IL-17F, and/or 0.5 ng/ml I…”
BackgroundInfluentialInfluenza A Exacerbates Staphylococcus aureus Pneumonia by Attenuating IL-1β Production in Mice
Robinson, K. M., Choi, S. M., McHugh, K. J., Mandalapu, S., Enelow, R. I., Kolls, J. K., & Alcorn, J. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301237 · Cited by 126
“In both IL-17RA2/2 mice and WT mice in which IL-17R and IL-22 were blocked, exogenous IL-1b did not prevent secondary bacterial pneumonia to the same degree as its effect on WT mice, suggesting that the Th17 axis plays an important role in IL-1b’s effect on influenza and S. aureus coinfection.”
BackgroundInfluentialRegulation of Gastric Carcinogenesis by Inflammatory Cytokines
Bockerstett, K. A., & DiPaolo, R. J. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.03.005 · Cited by 135
Roeleveld, D. M., & Koenders, M. I. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.006 · Cited by 142
“As this name suggests, this cytokine is a member of the IL-10-cytokine family showing an amino acid identity of 22% with IL-10 [53,54].”
BackgroundInfluentialLi, Q., Wang, B., Mu, K., & Zhang, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27180 · Cited by 144
The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
Egeberg, A., Gisondi, P., Carrascosa, J. M., Warren, R. B., & Mrowietz, U. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16273 · Cited by 133
The Biology and Functions of Th22 Cells
Jia, L., & Wu, C. Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_8 · Cited by 146
Novel insights into the role of S 100 A 8/ A 9 in skin biology
Kerkhoff, C., Voß, A., Scholzen, T. E., Averill, M. M., Zänker, K. S., & Bornfeldt, K. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01571.x · Cited by 138
Interplay between keratinocytes and immune cells—Recent insights into psoriasis pathogenesis
Tonel, G., & Conrad, C. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.022 · Cited by 140
Robust shifts in S100a9 expression with aging: A novel mechanism for chronic inflammation
Swindell, W. R., Johnston, A., Xing, X., Little, A., Robichaud, P., Voorhees, J. J., Fisher, G., & Gudjonsson, J. E. (2013) · Scientific Reports · doi:10.1038/srep01215 · Cited by 124
Berry, S. P. D.-G., Dossou, C., Kashif, A., Sharifinejad, N., Azizi, G., Hamedifar, H., Sabzvari, A., & Zian, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108402 · Cited by 124
Fish Cytokines and Immune Response
Reyes-Cerp, S., Maisey, K. R., Reyes‐López, F. E., Toro‐Ascuy, D., Mara, A. B., & Imarai, M. (2012) · InTech eBooks · doi:10.5772/53504 · Cited by 154
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation
Ouyang, X., Zhang, R., Yang, J., Li, Q., Qin, L., Zhu, C., Liu, J., Ning, H., Shin, M. S., Gupta, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1311 · Cited by 121
“In addition to H T H 2 cells, T H 17 cells have been identified more recently as a third T H subset mediating inflammatory and autoimmune responses through the production of interleukin (IL)-17A, IL-17F and IL-22 (refs 1–4).”
BackgroundMiani, M., Le Naour, J., Waeckel-Enée, E., Verma, S. C., Straube, M., Emond, P., Ryffel, B., van Endert, P., Sokol, H., & Diana, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.012 · Cited by 119
Nuovo, G. J., Hagood, J. S., Magro, C. M., Chin, N., Kapil, R., Davis, L., Marsh, C. B., & Folcik, V. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.166 · Cited by 123
“IL-17 enhances expression of S100 proteins in murine and human skin inflammation (33, 67).”
BackgroundIL-17 signaling in host defense against Candida albicans
Gaffen, S. L., Hernández-Santos, N., & Peterson, A. C. (2011) · Immunologic Research · doi:10.1007/s12026-011-8226-x · Cited by 121
“In skin, IL-22 and IL-17 cooperatively enhance expression of AMPs such as S100A7, S100A8 and S100A9 as well as β-defensins (41).”
BackgroundEmerging role of interleukin-22 in autoimmune diseases
Pan, H.-F., Li, X.-P., Zheng, S. G., & Ye, D.-Q. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.07.002 · Cited by 117
“IL-22 was originally thought to be a Th1-associated cytokine, it is now recognized that IL-22 is highly expressed by IL-17producing cells, called Th17 cells [2].”
BackgroundSingle-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis
Alkon, N., Bauer, W. M., Krausgruber, T., Goh, I., Griss, J., Nguyen, V., Reininger, B., Bangert, C., Staud, C. J., Brunner, P. M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.07.025 · Cited by 133
Miossec, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22733 · Cited by 127
Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate
Liao, J.-J., Huang, M.-C., & Goetzl, E. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5425 · Cited by 122
Verma, A. H., Wüthrich, M. D., Deepe, G. S., & Klein, B. S. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019612 · Cited by 132
“In mucosal infection models, IL-17 prompts keratinocytes and epithelial cells to release antimicrobial peptides (AMPs), such as S100A proteins, b-defensins, and histatins that show direct killing activity (Liang et al. 2006; Conti et al. 2011).”
Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
Pietrella, D., Rachini, A., Pines, M., Pandey, N., Mosci, P., Bistoni, F., d'Enfert, C., & Vecchiarelli, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022770 · Cited by 119
“Antimicrobial peptides have an important role in the innate immune response of host cells [21] and are secreted particularly by vaginal epithelial cells [26,27,28].”
BackgroundSystemic impact of intestinal helminth infections
Mishra, P. K., Palma, M., Bleich, D., Loke, P., & Gause, W. C. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.23 · Cited by 134
Cascão, R., Moura, R. A., Perpetuo, I. P., Canhão, H. M., Vieira‐Sousa, E., Mourão, A. F., Rodrigues, A. M., Pereira, J. P., Queiroz, M. V., Rosario, H., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3168 · Cited by 124
“Furthermore, the significantly higher circulating levels of IL-6 and IL-22 were maintained in established RA (Figure 3).”
BackgroundInfluentialCharacterization of IL-17A–Producing Cells in Celiac Disease Mucosa
Monteleone, I., Sarra, M., Del Vecchio Blanco, G., Paoluzi, O. A., Franzè, E., Fina, D., Fabrizi, A., MacDonald, T. T., Pallone, F., & Monteleone, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901919 · Cited by 122
“IL-22, a cytokine highly expressed by Th17 cells, has been reported to either promote (25, 26) or suppress (27, 28) chronic”
BackgroundIncreased frequencies of IL‐31‐producing T cells are found in chronic atopic dermatitis skin
Szegedi, K., Kremer, A. E., Kezic, S., Teunissen, M. B. M., Bos, J. D., Luiten, R. M., Res, P. C., & Middelkamp‐Hup, M. A. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01487.x · Cited by 121
Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk
Bastonini, E., Kovacs, D., & Picardo, M. (2016) · Annals of Dermatology · doi:10.5021/ad.2016.28.3.279 · Cited by 136
Interleukin‐23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy
Bridgewood, C., Sharif, Κ., Sherlock, J. P., Watad, ., & McGonagle, D. (2020) · Immunological Reviews · doi:10.1111/imr.12840 · Cited by 128
The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation
Maloy, K. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01950.x · Cited by 120
Bhaumik, S., & Basu, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00254 · Cited by 119
“However, re-stimulation in presence of exogenous TGFβ alone led to sustained expression of high IL-17A and IL-17F, while IL-23 failed to maintain IL-17A and IL-17F expression.”
BackgroundInfluentialHelper T-cell differentiation and plasticity: insights from epigenetics
Hirahara, K., Vahedi, G., Ghoreschi, K., Yang, X.-P., Nakayamada, S., Kanno, Y., O’Shea, J. J., & Laurence, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03483.x · Cited by 119
Host-microbial interactions in patients with chronic rhinosinusitis
Hamilos, D. L. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.049 · Cited by 117
“153 IL-22-mediated effects on airway epithelial cells require signaling through the IL-22 receptor (IL-22R) and activation of signal transducer and activator of transcription 3. 154 Il-23, produced mainly by phagocytes and dendritic cells, 155 is a crucial upstream regulator of IL-22 and IL-17 production.”
BackgroundPeng, Y., Han, G., Shao, H., Wang, Y., Kaplan, H. J., & Sun, D. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0251 · Cited by 119
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
Czarnowicki, T., He, H., Canter, T., Han, J., Lefferdink, R., Erickson, T., Rangel, S., Kameyama, N., Kim, H. J., Pavel, A. B., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.031 · Cited by 118
“Systemic/CLA2 TH22/TC22 subset development was similar in patients with AD and control subjects, potentially suggesting a greater pathogenic relevance of IL-22 in skin of patients with AD72 and the impaired skin barrier.73 Studies have shown positive correlations and cellular coproduction of IL-13 and IL-2222,74 and o…”
BackgroundDistinct roles of IL-22 in human psoriasis and inflammatory bowel disease
Ouyang, W. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.007 · Cited by 126
“It has been reported that IL-22 synergizes with IL-17 to enhance the induction of antimicrobial proteins from keratinocytes [17].”
BackgroundKrueger, J. G., & Brunner, P. M. (2018) · Experimental Dermatology · doi:10.1111/exd.13467 · Cited by 111
Therapeutic targets for rheumatoid arthritis: Progress and promises
Alghasham, A., & Rasheed, Z. (2014) · Autoimmunity · doi:10.3109/08916934.2013.873413 · Cited by 123
“It is also reported that this cytokine acts synergistically with IL-17 to induce genes associated with innate immunity in primary keratinocytes and this may have implications for defining their roles in RA [64].”
BackgroundZiesché, E., Bachmann, M., Kleinert, H., Pfeilschifter, J., & Mühl, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611040200 · Cited by 113
Schulz, S. M., Köhler, G., Schütze, N., Knauer, J., Straubinger, R. K., Chackerian, A. A., Witte, E., Wolk, K., Sabat, R., Iwakura, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7891 · Cited by 118
“Recently, Th17 cells were found to coexpress IL-17A and IL-22 in mice (40).”
BackgroundA catch‐22: Interleukin‐22 and cancer
Hernández, P. P., Gronke, K., & Diefenbach, A. (2018) · European Journal of Immunology · doi:10.1002/eji.201747183 · Cited by 125
Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
Woo, Y. R., Cho, D., & Park, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122684 · Cited by 132
“IL-17A induces the increased expression of antimicrobial peptides including β-defensin and S100A families, thereby activating the innate immune system [12].”
BackgroundMucosal cytokine network in inflammatory bowel disease
Andoh, A., Yagi, Y., Shioya, M., Nishida, A., Tsujikawa, T., & Fujiyama, Y. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5154 · Cited by 117
“Recent studies have shown that Th17 cells are a source of IL-22 [ 42 ,43]”
ResultProinflammatory cytokines underlying the inflammation of Crohnʼs disease
Strober, W., Zhang, F., Kitani, A., Fuss, I. J., & Fichtner‐Feigl, S. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328339d099 · Cited by 129
Interleukin-22: A likely target for treatment of autoimmune diseases
Yang, X., & Zheng, S. G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.008 · Cited by 123
Mechanisms controlling Th17 cytokine expression and host defense
McAleer, J. P., & Kolls, J. K. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0211099 · Cited by 108
“The main effector cytokines associated with Th17 cells include IL-17A (IL-17), IL-17F, and IL-22 [5, 6], and they may express any combination of these.”
BackgroundRecipient mucosal-associated invariant T cells control GVHD within the colon
Varelias, A., Bunting, M. D., Ormerod, K. L., Koyama, M., Olver, S. D., Straube, J., Kuns, R. D., Robb, R. J., Henden, A. S., Cooper, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci91646 · Cited by 107
Zhao, Y. G., Wang, Y., Guo, Z., Gu, A.-D., Dan, H. C., Baldwin, A. S., Hao, W., & Wan, Y. Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200919 · Cited by 120
“Nevertheless, DHA-mediated effects appeared to be gene specific, because the expression of certain Th17-related genes, such as IL-22 (19) and AhR (20), was not impaired by DHA treatment (Supplemental Fig.”
BackgroundSala, M., Elaïssari, A., & Fessi, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.003 · Cited by 127
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren-Wiemers, N., & Du Pasquier, R. A. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 107
Novak, N., & Simon, D. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02571.x · Cited by 113
Deligne, C., Casulli, S., Pigenet, A., Bougault, C., Campillo-Gimenez, L., Nourissat, G., Berenbaum, F., Elbim, C., & Houard, X. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.007 · Cited by 121
Saint‐Criq, V., Villeret, B., Bastaert, F., Kheir, S., Hatton, A., Cazes, A., Xing, Z., Sermet‐Gaudelus, I., García-Verdugo, I., Edelman, A., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210298 · Cited by 118
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
Kisand, K. E., & Peterson, P. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0176-y · Cited by 113
“Th17 cytokines (IL-17A, IL-17F and IL-22) influence epithelial cells by inducing the production of chemokines and antimicrobial peptides that exert direct antifungal activity [74, 75].”
BackgroundXue, J., Nguyen, D. T., & Habtezion, A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.051 · Cited by 120
Ikeda, U., Wakita, D., Ohkuri, T., Chamoto, K., Kitamura, H., Iwakura, Y., & Nishimura, T. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.07.002 · Cited by 126
CCL20, γδ T cells, and IL‐22 in corneal epithelial healing
Li, Z., Burns, A. R., Miller, S. B., & Smith, C. W. (2011) · The FASEB Journal · doi:10.1096/fj.11-184804 · Cited by 113
“T cells of the CCR6 IL17A phenotype, similar to Th17 cells (30), may also express IL-22 (24), a cytokine known to promote healing of some epithelial tissues (31) and to activate keratinocyte proliferation in IL-23dependent disease states such as psoriasis (32).”
BackgroundTakahashi, K., Hirose, K., Kawashima, S., Niwa, Y., Wakashin, H., Iwata, A., Tokoyoda, K., Renauld, J., Iwamoto, I., Nakayama, T., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.018 · Cited by 117
Targeting the Th17 pathway in psoriasis
Elloso, M. M., Gómez-Angelats, M., & Fourie, A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212101 · Cited by 117
“, -defensin-2), all of which may contribute to the recruitment and accumulation of neutrophils found in psoriasis lesions, thereby further promoting chronic inflammation [34, 36, 48].”
BackgroundÁlvarez-Luquín, D. D., Arce-Sillas, A., Leyva-Hernández, J., Sevilla-Reyes, E., Boll, M. C., Montes-Moratilla, E., Vivas-Almazán, V., Pérez-Correa, C., Rodríguez-Ortiz, U., Espinoza-Cárdenas, R., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1606-1 · Cited by 108
NK Cells Promote Th-17 Mediated Corneal Barrier Disruption in Dry Eye
Zhang, X., Volpe, E. A., Gandhi, N. B., Schaumburg, C. S., Siemasko, K. F., Pangelinan, S. B., Kelly, S. D., Hayday, A., Li, D.-Q., Stern, M. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036822 · Cited by 113
“[34,35] IL-17A has also been shown to promote production of IL-1, tumor necrosis factor a, IL-6, IL-8 and matrix metalloproteinases (MMPs) by epithelial cells and fibroblasts.”
BackgroundHidradenitis suppurativa: the role of immune dysregulation
Kelly, G., Sweeney, C. M., Tobin, A., & Kirby, B. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12550 · Cited by 131
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis
Leipe, J., Schramm, M. A., Grünke, M., Baeuerle, M., Dechant, C., Nigg, A. P., Witt, M., Vielhauer, V., Reindl, C., Schulze‐Koops, H., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152074 · Cited by 112
The CD4-centered universe of human T cell subsets
Geginat, J., Paroni, M., Facciotti, F., Gruarin, P., Kastirr, I., Caprioli, F., Pagani, M., & Abrignani, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.012 · Cited by 147
The skin surface as antimicrobial barrier: present concepts and future outlooks
Harder, J., Schröder, J., & Gläser, R. (2013) · Experimental Dermatology · doi:10.1111/exd.12046 · Cited by 107
Flannigan, K. L., & Denning, T. L. (2018) · Immunology · doi:10.1111/imm.12950 · Cited by 123
Chettri, J. K., Raida, M. K., Kania, P. W., & Buchmann, K. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.08.014 · Cited by 124
“This cytokine is involved in protection against bacterial pathogens by enhancing production of various antimicrobial peptides and pro-inflammatory cytokines in vertebrates (Liang et al., 2006; Wolk et al., 2004) and in rainbow trout IL-22 is associated with the expression of various antimicrobial peptides which sugges…”
BackgroundMurine NKT cells produce Th17 cytokine interleukin-22
Goto, M., Murakawa, M., Kadoshima-Yamaoka, K., Tanaka, Y., Nagahira, K., Fukuda, Y., & Nishimura, T. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.10.002 · Cited by 128
IL-17 in cutaneous lupus erythematosus
Tanasescu, C., Balanescu, A., Balanescu, P. C., Olteanu, R., Badea, C. G., Grancea, C., Vagu, C. D., Bleoţu, C., Ardeleanu, C. M., & Georgescu, A. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.03.004 · Cited by 115
“IL-17A and IL-17F are always synthesized in adimeric state (eitherhomodimeric IL-17A/IL-17A or IL-17F/IL-17F or heterodimeric IL-17A/IL-17F ) [13].”
BackgroundThe IL-23/IL-17 pathway in inflammatory bowel disease
Geremia, A., & Jewell, D. P. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.107 · Cited by 123
Major Role of γδ T Cells in the Generation of IL-17+ Uveitogenic T Cells
Cui, Y., Shao, H., Lan, C., Nian, H., O'Brien, R. L., Born, W. K., Kaplan, H. J., & Sun, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900241 · Cited by 110
Crosstalk: keratinocytes and immune cells in psoriasis
Kamata, M., & Tada, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286344 · Cited by 110
IL-23 Is Required for Protection against Systemic Infection with Listeria monocytogenes
Meeks, K. D., Sieve, A. N., Kolls, J. K., Ghilardi, N., & Berg, R. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901588 · Cited by 110
“IL-17A and IL-17F are known to induce antimicrobial peptides in addition to their ability to influence the recruitment and mobilization of neutrophils to sites of infection (7, 36, 46).”
BackgroundS100 family proteins in inflammation and beyond
Sreejit, G., Flynn, M., Patil, M., Krishnamurthy, P., Murphy, A. J., & Nagareddy, P. R. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.02.006 · Cited by 122
IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases
Sabat, R., Wallace, E., Endesfelder, S., & Wolk, K. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.601 · Cited by 108
“In contrast to the authors’ data, some studies describe effects of IL-19 on certain immune cell populations [23,30,5-52].”
BackgroundResultTargeting Interleukin-22 in Psoriasis
Hao, J. (2013) · Inflammation · doi:10.1007/s10753-013-9715-y · Cited by 117
“It was initially considered to be a Th1 cytokine; however, with the discovery of Th17, it has since been found to be most highly expressed by this new subset of T helper cells [6].”
InfluentialIL‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis
Kostic, M., Dzopalic, T., Zivanovic, S., Zivkovic, N., Cvetanovic, A., Stojanovic, I., Vojinovic, S., Marjanovic, G., Savic, V., & Colic, M. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12147 · Cited by 102
Epithelial-Immune Cell Interaction in Dry Eye
Pflugfelder, S. C., de Paiva, C. S., Li, D., & Stern, M. E. (2008) · Cornea · doi:10.1097/ico.0b013e31817f4075 · Cited by 113
Volpe, E., Touzot, M., Servant, N., Marloie-Provost, M.-A., Hupé, P., Barillot, E., & Soumelis, V. (2009) · Blood · doi:10.1182/blood-2009-05-223768 · Cited by 100
Cox, J. H., Kljavin, N. M., Ota, N., Leonard, J., Roose‐Girma, M., Diehl, L. J., Ouyang, W., & Ghilardi, N. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.54 · Cited by 120
Sanos, S. L., Vonarbourg, C., Mortha, A., & Diefenbach, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03410.x · Cited by 105
Furuhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S., & Morita, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054895 · Cited by 109
“Tip-DC and Th17 products activate keratinocytes, thereby promoting the release of innate inflammatory molecules [23], such Figure 3.”
BackgroundAtwa, M. A., Emara, A., Youssef, N., & Bayoumy, N. M. K. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12124 · Cited by 131
Role of interleukin-22 in inflammatory bowel disease
Li, L.-J., Gong, C., Zhao, M.-H., & Feng, B.-S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i48.18177 · Cited by 121
The Relapse of Psoriasis: Mechanisms and Mysteries
Tian, D., & Lai, Y. (2022) · JID Innovations · doi:10.1016/j.xjidi.2022.100116 · Cited by 118
Lackner, A. A., Lederman, M. M., & Rodriguez, B. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007005 · Cited by 140
“Cite this article as Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a007005 5 w w w .p er sp ec ti ve si n m ed ic in e. o rg which are critical for maintenance of the mucosal barrier (Kolls and Linden 2004; Liang et al. 2006).”
InfluentialFaure, E., Mear, J.-B., Faure, K., Normand, S., Couturier-Maillard, A., Grandjean, T., Balloy, V., Ryffel, B., Dessein, R., Chignard, M., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1358oc · Cited by 98
IL-22: There Is a Gap in Our Knowledge
Zenewicz, L. A. (2018) · ImmunoHorizons · doi:10.4049/immunohorizons.1800006 · Cited by 115
“With theadventof the identification of Th17 cells, IL-22 was quickly associated with these cells (23).”
BackgroundOkumura, R., & Takeda, K. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01026-5 · Cited by 121
“This contributes to regulating commensal bacteria and eliminating of pathogenic bacteria [84, 96].”
Mee, J. B., Johnson, C. M., Morar, N., Burslem, F., & Groves, R. W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061067 · Cited by 106
“Recent interest in the role of the Th17 effector lineage in psoriasis has yielded data indicating that Th17-associated cytokines up-regulate antimicrobial molecules, including 4 defensin and S100A9, in keratinocytes.(48) Although the transcriptome data presented strongly suggest a bias toward innate immune responses i…”
BackgroundRegulation of IL-17 production in human lymphocytes
Chen, Z., & O’Shea, J. J. (2007) · Cytokine · doi:10.1016/j.cyto.2007.09.009 · Cited by 120
Pallikkuth, S., Micci, L., Ende, Z. S., Iriele, R. I., Cervasi, B., Lawson, B., McGary, C. S., Rogers, K. A., Else, J. G., Silvestri, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003471 · Cited by 105
Matsuzaki, G., & Umemura, M. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12560 · Cited by 113
“IL-17F was originally identified as a Th17-derived cytokine (105).”
BackgroundInterleukin-10 Family Cytokines Immunobiology and Structure
Wei, H.-X., Li, B., Sun, A., & Guo, F. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9367-9_4 · Cited by 106
Navarro‐Compán, V., Puig, L., Vidal, S., Ramírez, J., Llamas‐Velasco, M., Fernández‐Carballido, C., Almodóvar, R., Pinto, J., Galíndez‐Aguirregoikoa, E., Zarco, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191782 · Cited by 135
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications
Marinoni, B., Ceribelli, A., Massarotti, M. S., & Selmi, C. (2014) · Autoimmunity Highlights · doi:10.1007/s13317-013-0057-4 · Cited by 105
The Gastrointestinal Tract and AIDS Pathogenesis
Lackner, A. A., Mohan, M., & Veazey, R. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.071 · Cited by 124
Metadata
- Authors
- Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A.
- Affiliations
- 1Inflammation
- 2Antibody Technologies Group, Wyeth Research, Cambridge, MA 02140
- Wyeth (US)
- ORCID
- Collins, Mary
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-09-18
- Volume
- 203
- Issue
- 10
- Pages
- 2271-2279
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118116
- OpenAlex
- W2139008734
- Cited by
- 2,330
- References
- 19
- Citations by year
- 2026: 57 · 2025: 61 · 2024: 80 · 2023: 74 · 2022: 93 · 2021: 118 · 2020: 127 · 2019: 104 · 2018: 104 · 2017: 112 · 2016: 126 · 2015: 132 · 2014: 145 · 2013: 147 · 2012: 156
- FWCI
- 47.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- IL-22, IL-17A, IL-17F, Th17 cells, antimicrobial peptides, human beta-defensin 2, S100A7, S100A8, S100A9, keratinocytes, skin innate immunity, IL-23, interleukin-6, TGF-beta signaling, cytokine synergy
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Immunity, Innate, Interleukins, Mice, Transgenic, Signal Transduction, CD4-Positive T-Lymphocytes, Keratinocytes, Polymerase Chain Reaction, Transforming Growth Factor beta, Interleukin-17, Antimicrobial Cationic Peptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.